🇺🇸 FDA
Patent

US 10905721

Device and methods for platelet lysis or activation

granted A61KA61K35/19A61K45/06

Quick answer

US patent 10905721 (Device and methods for platelet lysis or activation) held by Regenexx, LLC expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regenexx, LLC
Grant date
Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/19, A61K45/06